Clinical trial
Dendritic Cell Based Therapy of Metastatic Breast Cancer
NCT00197925 · Herlev Hospital, Other · Terminated
Key facts
| NCT number | NCT00197925 |
|---|---|
| Title | Dendritic Cell Based Therapy of Metastatic Breast Cancer |
| Official title | Vaccination With Autologous Dendritic Cells Pulsed With Onco-Peptides for Treatment of Patients With Metastatic Breast Cancer.A Phase I/II Study |
| Lead sponsor | Herlev Hospital, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Metastatic Breast Cancer |
| Intervention type | Biological |
| Interventions | Onco-peptide loaded autologous dendritic cells |
| Enrollment | 40 |
| Start date | Sep 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Jan 3, 2008 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: